Pharmacy
The Food and Drug Administration on Wednesday approved acute lymphoblastic leukemia treatment Kymriah, that comes with a $475,000 price tag.
Novartis officials said it is working with 20 hospitals to provide Kymriah within a month.
Anthem-affiliated health plans are limited to seven days for the initial prescription for short-acting opioids.
Envelope flaw allowed others to see patient information on options Aetna's health plan offers when filling prescriptions.
Interventions lead to fewer prescriptions, less opioid consumption by aggressively limiting opioid dose and duration of therapy at the initial first fill.
Settlement resolves allegations that Celgene promoted cancer drugs Thalomid, Revlimid for uses not approved by the FDA.
Roughly 45 percent of urgent care facility visits by Cigna members could be conducted at retail healthcare clinics, insurer says.
Congressional donations from pharma PACs rose 11 percent in this year's first quarter, compared to first quarter 2015, Kaiser analysis shows.
The agreement settles allegations that Walmart failed to confirm and document the necessary diagnoses for Code 1 drugs.
One of the main culprits is the "buy-and-bill" reimbursement model for infused therapies.